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Zinc is the constituent element of insulin and is an essential element for the func-
tion of some enzymes, such as carbonic anhydrase, carboxypeptidase and alcohol de-
hydrogenase. Deficiency of zinc in the media of the tissue culture of mammalian 
kidneys causes inhibition of the biosyntheses of thiamine kinase and deoxyribonucleic 
acid. 
On the other hand, most of the amino acids have an ability to form metal com-
plexes. In food technology, the ability of amino acids as sequestering agents for transi-
tional metal elements is applied to the prevention of the autoxidation of glycerides. 
Among numerous amino acids, histidine is of great interest because the imidazole group 
forms 7T-bonds with metal elements. 
Most of the researches on the zinc-histidine complexes so far published are con-
cerned with equilibria in the complex formations 1l-4 l or with crystallographic analyses 
of the complexes. sl 6 l Such results are not available for considering the biochemical 
roles of zinc and histidine. Know ledges wanted for understanding biochemical phenome-
na, such as an enzyme action or a protein denaturation are the effects of pH on the 
formation of zinc-histidine complexes in aqueous solution. Accordingly, the formation 
of zinc-complexes with histidine and the related compounds in aqueous solution are 
dealt with in this paper. 
MATERIALS AND METHODS 
1. Materials 
All the reagents used m this experiment were of guaranteed grade, and distilled-
deionized water was used in the preparation of the various samples. A stock solution 
of ZnS04 was prepared so as to contain 1.8 or 3.6 X l0-3 M Zn and the Zn concentra-
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tion was determined with a Hitachi 207 atomic absorption spectrophotometer. Each 
stock solution of ligands contained 3.6 X I 0 -3M ligand. The ligand concentration was 
determined by the potentiometric titration method. As ligand, the following reagents 
were used: L-histidine monohydrochloride (Wako Pure Chemical Co., Ltd.), L-histidine 
dihydrochloride (Nakarai Chemicals Co., Ltd.), L-histidylglycine (SIGMA Chemicals 
Co., Ltd.), glycyl-L-histidine (SIGMA Chemicals Co., Ltd.) and glycylglycine (Wako 
Pure Chemical Co., Ltd.). 
2. Potentiometric titration 
Potentiometric titrations were carried out with a Hiranuma RAT-IOIS autorecord-
ing potentiometric titration apparatus using a combination electrode MC 30. The 
samples were mixed solutions in which Zn and a ligand were dissolved in the molar ratio 
of Zn : ligand as I : I or I : 2. The ionic strength (p) of these solutions was adjusted 
to 0.1 with NaCI04 solution before titration. Titrations were made with 0.1 N NaOH 
in a stream of N2 gas at 25 ± 0.5°C. As a control, the ligand was titrated in the absence 
of Zn under the same conditions. 
RESULTS 
Titration curves obtained for Zn-histidine (His), -histamine (Hista), -histidine 
methylester (HisMe), -histidylglycine (HisGly), -glycylhistidine (GiyHis) and -glycyl-
glycine (GlyGiy) systems are shown in Fig. I. Decreases of pH were observed in all 
the Zn-ligand systems. The lowering of pH was caused by a release of protons from 
donor groups and is regarded as an index of the Zn-complex formation. The dissociation 
constant of each ligand and the pH range of the lowering are indicated in Table I. 
DISCUSSION 
1. Zn-His complexes 
In the titration curves of Zn-His systems, there was a remarkable inflection at a = 
2; a representing the number of equivalents, mole number, of NaOH added per mole of 
a ligand (Fig. 1-1). This fact indicates that two protons per mole of His are liberated 
in the Zn-His complex formation. His molecule has three donor groups, namely, a-
NH2, a-COOH and imidazole groups, and two of them contribute to the formation 
of the Zn-complex. For the chemical structure of Zn-His complex satisfying the above 
conditions, one of the Formulae I, 11 and Ill in Fig. 2 is assumed. The chelate rings 
of I, 11 and Ill are 7-, 5- and 6-membered, respectively. In general, stable chelate 
compounds have 5- or 6-membered rings. 7> The possibility of Formula I can thus be 
excluded. The chelate ring of 11 formed by the participation of a-NH 2 and a-COOH 
groups resembles that of Formula IV for the Zn-Giy complex. From the stability 
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Fig. 1. Potentiometric titration curves of various Zn-ligand systems. 
Control solution contained ligand alone 
Reaction solution contained Zn and a ligand in the molar ratio of 1 : 1 
Reaction solution contained Zn and a ligand in the molar ratio of 1 : 2 
Moles of NaOH added per mole of a ligand. 
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constants of Zn-His complex ( 12.00) and Zn-Gly complex (9 .30), ALBERT2 ) proposed 
Formula III for the Zn-His (I : 2) complex and attributed the high stability of the 
Zn-His complex to the participation of the imidazole group. EDSALL et al. s) reported 
that the binding ability of His to metal ions was due to the o:-NH2 and the imidazole 
groups. Formula Ill, accordingly, is postulated for the probable structure of the Zn-His 
( 1 : 2) complex. 
As above-mentioned, if the o:-COOH group of His does not participate in the for-
mation of the Zn-His complex, the titration curves of Zn-Hista systems would resemble 
those of Fig. 1-1, and the structure of the Zn-Hista complex would have a chelate ring 
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similar to that of the Zn-His complex as shown in Formula V. There were obseiVed, 
however, two different points between their titration cuiVes: the values of a and pH 
at the beginning of the protonations. In the case of the Zn-Hista systems, the protona-
tion occurred at the middle point of a = o~ I (Fig. 1-2). The pH value at the point 
is about 6 which is compatible with the pK2 value of His, i.e., the acid-dissociation 
constant of the imidazole group. As to the Zn-His systems, the protonation occurred 
at the point of a = 0 and below pH 6 (Fig. 1-1 ). The protonation below pH 6 is 
considered to be due to the dissociation of the o:-COOH group. Consequently, for 
the Zn-His complex in an aqueous solution below pH 6 other formulae than Ill may be 
postulated, where the participation of the o:-COOH group should be taken into considera-
tion. As an example for this Formula VII may be given. 
Table 1. Protonation of histidine and the related compounds 
in the formation of zinc (11)-<:omplexes. 
Acid-dissociation Molar ratio pH area of Mole number of OH Ligand constant of of protonation consumed per ligand Zn: ligand mole of ligand 
pK2 6.1 ± 0.1 1 : 1 4.6 ~ 8.0 (ppt) 2 His 
pK3 9.1 ± 0.1 1:2 4.6 ~ 9.8 (ppt) 2 
pK, 6.2 ± 0.1 1 : 1 6.0 ~ 7.8 (ppt) 2 Hista 
pK2 9.7 ± 0.1 1 : 2 6.0 ~ 8.3 (ppt) 2 
pK, 5.3 ± 0.1 1 : 1 4.0 ~ 7.8 (ppt) 2 HisMe 
PK2 7.3 ± 0.1 1 : 2 4.0 ~ 8.5 (ppt) 2 
pK2 5.9 ± 0.1 1 : 1 4.7 ~ 8.1 (ppt) 3 HisGly 
pK3 7.7 ± 0.1 1 : 2 4. 7 ~ (no ppt) 3 
pK2 = 6.8 ± 0.1 GlyHis 
8.3 ± 1 : 1 5.0 ~ 8.5 (ppt) 3 pK3 0.1 
GlyGly 8.2 ± 1 : 1 5.0 ~ 7.6 (ppt) 3 pK2 0.1 
1:2 5.7 ~ 8.5 (ppt) 3 
Gly pK2 9.6 ± 0.1 
1 : 1 5.6 ~ 7.7 (ppt) 
1 : 2 5.6 ~ 8.9 (ppt) 
(t = 25°C, J1 = 0.1) 
For further examinations on the contribution of the o:-COOH group to the Zn-
complex formation, potentiometric titrations on Zn-HisMe systems were carried out 
(Fig. 1-3). The reason for selecting HisMe is that the COOH group ofHisMe is masked 
with CH 3 • The titration CUIVes of the Zn-HisMe systems resemble considerably those 
of the Zn-His systems. Therefore, the chemical structure of the Zn-HisMe complex is 
assumed to be illustrated by Formula VI in Fig. 2. 
In the case of the Zn-His system, Formula VII was given as a possible structure 
for the complex in acidic solution. The structure is made up of 1 : 1 molar ratio of 
Zn to His: The Zn-His ( 1 : 2) complex seems improbable. since the coordination 
number of Zn is usually four. 
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2. Zn-His containing dipeptide complexes 
As mentioned above, the behavior of His in free state provided some valuable 
information on the participation of the NH 2 or the COOH group in the formation of 
Zn-His complexes. It appeared desirable to examine the behavior of His in combined 
state, the suitable choice being His containing dipeptides of which the NH 2 or the 
COOH group of His took part in the peptide linkage formation. Accordingly, Zn-
HisGly, -GlyHis and -GlyGly systems were examined and the results are shown in 
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Fig. 2. Assumed chemical structures for Zn-complexes of His and the related compounds. 
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Fig. 1-4, 1-5, and 1-6, respectively. The reason for selecting Gly as the other amino 
acid residue is that Gly has no side chain. 
In Fig. 1-4, the titration curves in the region of a = 1 -3 resemble those of 
the Zn-His system. The results indicate that two donor groups of HisGly coordinate 
to the Zn ion. HisGly has four donor groups, i.e., the a-NH2 and the imidazole groups 
of His residue, the a-COOH group of Gly residue and the NH group of the peptide 
linkage. Accordingly, it is necessary to make clear which two groups of the four would 
participate in the Zn-complex formation. The possibility of the participation of the 
NH group of the peptide linakge is probably excluded because of the difficulty of 
dissociating the proton at pH values near neutrality. If the COOH group participates, 
the resulting complex would have an 8-membered chelate ring in the structure. Such a 
structure seems improbable because of its instability. The residual two groups are 
the imidazole and _the a-NH2 groups of His residue. Therefore, the structure of the Zn-
HisGly complex is assumed to be illustrated by Formula VIII in Fig. 2. 
In the region of a = 3 -4, the titration curves of the Zn-HisGly ( l : l) system 
show the second lowering of pH, namely, the second protonation which indicates the 
formation of another complex. The protonation is considered to be due to the dis-
sociation of the NH group of the peptide linkage, because the ·other three groups of 
HisGly should have already been dissociated below a = 3. · For the structure of the Zn-
complex, either IX or X is assumed. The chelate ring of Formula IX resembles that 
of Formula IV for the Zn-Gly complex. The stability of metal chelate complexes in 
general increases with number of the chelate ring of the structures. Formula X, accord-
ingly, is given as ,a more possible structure than IX. 
GlyHis is the isomer of HisGly in r~gard to the terminal NH2 and COOH groups. 
The titration curves of the Zn-GlyHis systems are illustrated in Fig. l-5. The results 
indicate that the liberation of two or three protons per mole of GlyHis occurred in 
the Zn-complex formation. When the number of the proton released is three, Formula 
XI or XII is probably given for the complex. Both formulae have two chelate rings. 
Fig. 1-6 shows the titration curves of the Zn-GlyGly systems. It should be 
mentioned that the precipitation of Zn(OHh occurred in the earlier stages of the 
titrations, especially in the case of the ( 1 : 2) system. Similar results were obtained also 
with Zn-Gly systems, although the titration curves were not revealed (see Table l). 
A feature common to the Zn-Gly and the Zn-GlyGly systems is that only Gly coordinates 
to the Zn ion. In view of these facts, it may generally be said that the participation 
of the imidazole group of His is important in the stabilization of the Zn-complexes. 
For the structure of the Zn-GlyGly complex, Formula XIII may be postulated by 
reference to the structure proposed for the Cu-GlyGly complex by DORAN et al. 9) 
In this investigation, none of the Zn-HisHis systems were examined. The structure 
of the Zn-complex, however, can be illustrated as Formula XIV or XV by reference 
to the DORAN's paper on the Cu-HisHis complex.9> 
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SUMMARY 
Formations of Zn-histidine, -histamine, -histidine methylester, -histidylglycine, 
-glycylhistidine and -glycylglycine complexes in aqueous solution were examined by 
means of a potentiometric titration method. On the basis of the results obtained the 
possible chemical structures were given to the individual complexes. The main object 
of this investigation is to know what donor groups of histidine participate in the Zn-
complex formation at a given pH value. 
In neutral and alkaline solutions above pH 6, the imidazole and the a-NH2 groups 
of histidine coordinate to the Zn ion and form the Zn-histidine ( l : 2) complex. In 
acidic solutions, the a-COOH group also coordinates and forms the Zn-histidine (l : 1) 
complex together with the above two groups. The complexes formed by the participa-
tion of the imidazole group of histidine are considered to be more stable than the Zn-
glycine or -glycylglycine complex by reason of the difficulty in the precipitation of 
Zn(OHh during the titrations. This was also the case for the Zn-histidine-containing 
dipeptide complexes. 
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Hisならびにペプチドの構成単位となった His残基lζ分けて検討した。
まず， pH6以上の中性およびアJレカリ性溶液中ではイミダゾーノレ -NHと α-NH2が配位するととを推測
し.Fig.2の式Eを示した。またHistaおよび HisMeと比較するととによって， α-COOH基の影響もあり
得ると考え，式VIを示した。
次l乙全く側鎖をもたない Glyと Hisから成るジペプチドすなわち HisGlyおよび GlyHisを比較し
さらに GlyGlyと比べる乙とによって，イミダゾール核がZn錯体を安定化させ， Zn(OH)2の沈澱形成を
かなり抑制する ζとについて考察を加えた。
との種の報文はノ'J;なしとくに Hisを含むペプチドと Znの錯体生成lζ関する報文は始めてのものである。
